Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Jun;63(6):893–896. doi: 10.1038/bjc.1991.196

Sera from patients with colon, breast and lung cancer induce resistance to lysis mediated by NK cytotoxic factors (NKCF).

M Marubayashi 1, R Solana 1, R Ramirez 1, E Aranda 1, F Galan 1, J Peña 1
PMCID: PMC1972553  PMID: 1906292

Abstract

Natural killer (NK) cells are involved in the antitumoral immunologic mechanism. These cells act through the release of cytotoxic molecules defined as NK cytotoxic factors (NKCF). Inhibitory factors of NK and NKCF mediated lysis have been described in in vitro assays. This study evaluates the induction of resistance to NKCF cytotoxicity by sera from 27 patients with colon, breast and lung cancer. Addition of these sera to the cytolytic assay where K562 cells and concentrated NKCF were used, induced resistance to NKCF mediated cytotoxicity in 21 cases (77%). The sera from the group with metastasis blocked NKCF lysis more markedly than the group with local tumours. However, no differences were observed when the groups with colon, breast and lung cancers were compared. This blocking effect was not found to be related to gamma interferon (IFN) levels. In a previous study, we described a tumour factor (NK-RIF) produced by human cell lines derived from metastatic adenocarcinomas. This factor blocked lysis of tumour target cells by NK cells. Consequently, it is proposed that the release of similar tumour factors with a capacity to induce resistance to NKCF may be involved in tumour growth and metastatic spreading in in vivo.

Full text

PDF
893

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alonso C., Serrano R., Solana R., Peña J. Natural killer susceptibility of brain tumor cell lines inversely correlates with the degree of cell differentiation and not with the level of human histocompatibility antigen expression. Int Arch Allergy Appl Immunol. 1989;89(2-3):169–172. doi: 10.1159/000234941. [DOI] [PubMed] [Google Scholar]
  2. Brenner B. G., Benarrosh S., Margolese R. G. Peripheral blood natural killer cell activity in human breast cancer patients and its modulation by T-cell growth factor and autologous plasma. Cancer. 1986 Aug 15;58(4):895–902. doi: 10.1002/1097-0142(19860815)58:4<895::aid-cncr2820580416>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  3. Grossi C. E., Cadoni A., Zicca A., Leprini A., Ferrarini M. Large granular lymphocytes in human peripheral blood: ultrastructural and cytochemical characterization of the granules. Blood. 1982 Feb;59(2):277–283. [PubMed] [Google Scholar]
  4. Grossi C. E., Webb S. R., Zicca A., Lydyard P. M., Moretta L., Mingari M. C., Cooper M. D. Morphological and histochemical analyses of two human T-cell subpopulations bearing receptors for IgM or IgG. J Exp Med. 1978 May 1;147(5):1405–1417. doi: 10.1084/jem.147.5.1405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Harris D. T., Cianciolo G. J., Snyderman R., Argov S., Koren H. S. Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E. J Immunol. 1987 Feb 1;138(3):889–894. [PubMed] [Google Scholar]
  6. Herberman R. B., Holden H. T. Natural cell-mediated immunity. Adv Cancer Res. 1978;27:305–377. doi: 10.1016/s0065-230x(08)60936-7. [DOI] [PubMed] [Google Scholar]
  7. Herberman R. B., Reynolds C. W., Ortaldo J. R. Mechanism of cytotoxicity by natural killer (NK) cells. Annu Rev Immunol. 1986;4:651–680. doi: 10.1146/annurev.iy.04.040186.003251. [DOI] [PubMed] [Google Scholar]
  8. Hercend T., Schmidt R., Brennan A., Edson M. A., Reinherz E. L., Schlossman S. F., Ritz J. Identification of a 140-kDa activation antigen as a target structure for a series of human cloned natural killer cell lines. Eur J Immunol. 1984 Sep;14(9):844–852. doi: 10.1002/eji.1830140914. [DOI] [PubMed] [Google Scholar]
  9. James K. Interactions between cytokines and alpha 2-macroglobulin. Immunol Today. 1990 May;11(5):163–166. doi: 10.1016/0167-5699(90)90067-j. [DOI] [PubMed] [Google Scholar]
  10. Johnson P. W., Trimble W. S., Hozumi N., Roder J. C. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells. J Immunol. 1987 Jun 1;138(11):3996–4003. [PubMed] [Google Scholar]
  11. Kärre K., Ljunggren H. G., Piontek G., Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 1986 Feb 20;319(6055):675–678. doi: 10.1038/319675a0. [DOI] [PubMed] [Google Scholar]
  12. Lin C. C., Kuo Y. C., Huang W. C., Lin C. Y. Natural killer cell activity in lung cancer patients. Chest. 1987 Dec;92(6):1022–1024. doi: 10.1378/chest.92.6.1022. [DOI] [PubMed] [Google Scholar]
  13. Ljunggren H. G., Kärre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today. 1990 Jul;11(7):237–244. doi: 10.1016/0167-5699(90)90097-s. [DOI] [PubMed] [Google Scholar]
  14. Natuk R. J., Welsh R. M. Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication. J Immunol. 1987 Feb 1;138(3):877–883. [PubMed] [Google Scholar]
  15. Pena J., Solana R., Alonso M. C., Santamaria M., Serrano R., Ramirez R., Carracedo J. MHC class I expression on human tumour cells and their susceptibility to NK lysis. J Immunogenet. 1989 Aug-Oct;16(4-5):407–412. doi: 10.1111/j.1744-313x.1989.tb00488.x. [DOI] [PubMed] [Google Scholar]
  16. Peña J., Alonso C., Solana R., Serrano R., Carracedo J., Ramirez R. Natural killer susceptibility is independent of HLA class I antigen expression on cell lines obtained from human solid tumors. Eur J Immunol. 1990 Nov;20(11):2445–2448. doi: 10.1002/eji.1830201113. [DOI] [PubMed] [Google Scholar]
  17. Powell L. D., Whiteheart S. W., Hart G. W. Cell surface sialic acid influences tumor cell recognition in the mixed lymphocyte reaction. J Immunol. 1987 Jul 1;139(1):262–270. [PubMed] [Google Scholar]
  18. Rodgers K. E., Grayson M. H., Ware C. F. Inhibition of cytotoxic T lymphocyte and natural killer cell-mediated lysis by O,S,S,-trimethyl phosphorodithioate is at an early postrecognition step. J Immunol. 1988 Jan 15;140(2):564–570. [PubMed] [Google Scholar]
  19. Roozemond R. C., Mevissen M., Urli D. C., Bonavida B. Effect of altered membrane structure on NK cell-mediated cytotoxicity. III. Decreased susceptibility to natural killer cytotoxic factor (NKCF) and suppression of NKCF release by membrane rigidification. J Immunol. 1987 Sep 1;139(5):1739–1746. [PubMed] [Google Scholar]
  20. Saksela E., Timonen T., Ranki A., Häyry P. Morphological and functional characterization of isolated effector cells responsible for human natural killer activity to fetal fibroblasts and to cultured cell line targets. Immunol Rev. 1979;44:71–123. doi: 10.1111/j.1600-065x.1979.tb00268.x. [DOI] [PubMed] [Google Scholar]
  21. Schantz S. P., Campbell B. H., Guillamondegui O. M. Pharyngeal carcinoma and natural killer cell activity. Am J Surg. 1986 Oct;152(4):467–474. doi: 10.1016/0002-9610(86)90326-0. [DOI] [PubMed] [Google Scholar]
  22. Serrano R., Alonso C., Solana R., Monserrat J., Muñoz J., Peña J. Identification of a tumour factor inducing resistance to NK cell lysis. Immunol Lett. 1989 Mar;20(4):311–316. doi: 10.1016/0165-2478(89)90040-0. [DOI] [PubMed] [Google Scholar]
  23. Serrano R., Yiangos Y. G., Solana R., Sachs J. A., Pena J. Isolation of a novel tumor protein that induces resistance to natural killer cell lysis. J Immunol. 1990 Nov 15;145(10):3516–3523. [PubMed] [Google Scholar]
  24. Solana R., Serrano R., Peña J. MHC antigens in NK cell recognition and lysis. Immunol Today. 1991 Feb;12(2):95–95. doi: 10.1016/0167-5699(91)90168-S. [DOI] [PubMed] [Google Scholar]
  25. Stern P., Gidlund M., Orn A., Wigzell H. Natural killer cells mediate lysis of embryonal carcinoma cells lacking MHC. Nature. 1980 May 29;285(5763):341–342. doi: 10.1038/285341a0. [DOI] [PubMed] [Google Scholar]
  26. Tartter P. I., Steinberg B., Barron D. M., Martinelli G. The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer. Arch Surg. 1987 Nov;122(11):1264–1268. doi: 10.1001/archsurg.1987.01400230050009. [DOI] [PubMed] [Google Scholar]
  27. Timonen T., Ortaldo J. R., Herberman R. B. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med. 1981 Mar 1;153(3):569–582. doi: 10.1084/jem.153.3.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Trinchieri G., Perussia B. Human natural killer cells: biologic and pathologic aspects. Lab Invest. 1984 May;50(5):489–513. [PubMed] [Google Scholar]
  29. Vodinelich L., Sutherland R., Schneider C., Newman R., Greaves M. Receptor for transferrin may be a "target" structure for natural killer cells. Proc Natl Acad Sci U S A. 1983 Feb;80(3):835–839. doi: 10.1073/pnas.80.3.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Wei W. Z., Heppner G. Natural killer activity of lymphocytic infiltrates in mouse mammary lesions. Br J Cancer. 1987 Jun;55(6):589–594. doi: 10.1038/bjc.1987.120. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES